FCN-411
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FCN-411, covering 2020-07-16 to 2020-07-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation [Phase 1, Phase 2]